APO RESEARCH · REPORT
Novel Drug Delivery Systems
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Product & engineering
Understand the product.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Selected research
Industry Growth & Trends
Global Novel Drug Delivery Systems Industry Growth and Trends Forecast to 2032
Market perspective
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
According to APO Research, the global Novel Drug Delivery Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Novel Drug Delivery Systems market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Novel Drug Delivery Systems market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Novel Drug Delivery Systems market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Novel Drug Delivery Systems.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Novel Drug Delivery Systems market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Novel Drug Delivery Systems Market by Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Novel Drug Delivery Systems Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Novel Drug Delivery Systems Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
Novel Drug Delivery Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Novel Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Novel Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Novel Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Novel Drug Delivery Systems companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
- Others
Applications
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
Companies covered
- Amgen
- Teva
- Roche
- UCB (Union Chimique Belge)
- Celgene
- Merck
- Gilead Sciences
- Sanofi
- Pfizer
- Takeda
- Bausch&Lomb
- Samyang Biopharmaceuticals
- Johnson & Johnson
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
- AstraZeneca
- Aspen
- Acrotech Biopharma
- TWi Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Novel Drug Delivery Systems Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Novel Drug Delivery Systems Market Size by Region (2021-2032)
- 1.4.1 Global Novel Drug Delivery Systems Market Size by Region (2021-2026)
- 1.4.2 Global Novel Drug Delivery Systems Market Size by Region (2027-2032)
- 1.5 Key Regions Novel Drug Delivery Systems Market Size (2021-2032)
- 1.5.1 North America Novel Drug Delivery Systems Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Novel Drug Delivery Systems Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (2021-2032)
- 1.5.4 South America Novel Drug Delivery Systems Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (2021-2032)
2 Novel Drug Delivery Systems Market by Type
- 2.1 Type Introduction
- 2.1.1 Liposomes
- 2.1.2 PEGylated Proteins & Polypeptides
- 2.1.3 Polymer Nanoparticle
- 2.1.4 Protein–drug Conjugates
- 2.1.5 Others
- 2.2 Global Novel Drug Delivery Systems Market Size by Type
- 2.2.1 Global Novel Drug Delivery Systems Market Size Overview by Type (2021-2032)
- 2.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Type (2027-2032)
- 2.3 Global Novel Drug Delivery Systems Market Size by Regions
- 2.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Novel Drug Delivery Systems Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Type (2021-2026)
3 Novel Drug Delivery Systems Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals & Clinic
- 3.1.2 Cancer Treatment Centers
- 3.1.3 Others
- 3.2 Global Novel Drug Delivery Systems Market Size by Application
- 3.2.1 Global Novel Drug Delivery Systems Market Size Overview by Application (2021-2032)
- 3.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Application (2027-2032)
- 3.3 Global Novel Drug Delivery Systems Market Size by Regions
- 3.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Novel Drug Delivery Systems Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Novel Drug Delivery Systems Industry Trends
- 4.2 Novel Drug Delivery Systems Industry Drivers
- 4.3 Novel Drug Delivery Systems Industry Opportunities and Challenges
- 4.4 Novel Drug Delivery Systems Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Novel Drug Delivery Systems Revenue (2021-2026)
- 5.2 Global Novel Drug Delivery Systems Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Novel Drug Delivery Systems Key Company Headquarters & Area Served
- 5.4 Global Novel Drug Delivery Systems Company, Product Type & Application
- 5.5 Global Novel Drug Delivery Systems Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Novel Drug Delivery Systems Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Novel Drug Delivery Systems Players Market Share by Revenue in 2025
- 5.6.3 2025 Novel Drug Delivery Systems Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Amgen
- 6.1.1 Amgen Company Information
- 6.1.2 Amgen Business Overview
- 6.1.3 Amgen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Amgen Novel Drug Delivery Systems Product Portfolio
- 6.1.5 Amgen Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Teva Novel Drug Delivery Systems Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Roche
- 6.3.1 Roche Company Information
- 6.3.2 Roche Business Overview
- 6.3.3 Roche Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Roche Novel Drug Delivery Systems Product Portfolio
- 6.3.5 Roche Recent Developments
- 6.4 UCB (Union Chimique Belge)
- 6.4.1 UCB (Union Chimique Belge) Company Information
- 6.4.2 UCB (Union Chimique Belge) Business Overview
- 6.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Portfolio
- 6.4.5 UCB (Union Chimique Belge) Recent Developments
- 6.5 Celgene
- 6.5.1 Celgene Company Information
- 6.5.2 Celgene Business Overview
- 6.5.3 Celgene Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Celgene Novel Drug Delivery Systems Product Portfolio
- 6.5.5 Celgene Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Merck Novel Drug Delivery Systems Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Gilead Sciences
- 6.7.1 Gilead Sciences Company Information
- 6.7.2 Gilead Sciences Business Overview
- 6.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Gilead Sciences Novel Drug Delivery Systems Product Portfolio
- 6.7.5 Gilead Sciences Recent Developments
- 6.8 Sanofi
- 6.8.1 Sanofi Company Information
- 6.8.2 Sanofi Business Overview
- 6.8.3 Sanofi Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Sanofi Novel Drug Delivery Systems Product Portfolio
- 6.8.5 Sanofi Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Pfizer Novel Drug Delivery Systems Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 Takeda
- 6.10.1 Takeda Company Information
- 6.10.2 Takeda Business Overview
- 6.10.3 Takeda Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Takeda Novel Drug Delivery Systems Product Portfolio
- 6.10.5 Takeda Recent Developments
- 6.11 Bausch&Lomb
- 6.11.1 Bausch&Lomb Company Information
- 6.11.2 Bausch&Lomb Business Overview
- 6.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bausch&Lomb Novel Drug Delivery Systems Product Portfolio
- 6.11.5 Bausch&Lomb Recent Developments
- 6.12 Samyang Biopharmaceuticals
- 6.12.1 Samyang Biopharmaceuticals Company Information
- 6.12.2 Samyang Biopharmaceuticals Business Overview
- 6.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 6.12.5 Samyang Biopharmaceuticals Recent Developments
- 6.13 Johnson & Johnson
- 6.13.1 Johnson & Johnson Company Information
- 6.13.2 Johnson & Johnson Business Overview
- 6.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Johnson & Johnson Novel Drug Delivery Systems Product Portfolio
- 6.13.5 Johnson & Johnson Recent Developments
- 6.14 TOLMAR
- 6.14.1 TOLMAR Company Information
- 6.14.2 TOLMAR Business Overview
- 6.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 TOLMAR Novel Drug Delivery Systems Product Portfolio
- 6.14.5 TOLMAR Recent Developments
- 6.15 Astellas
- 6.15.1 Astellas Company Information
- 6.15.2 Astellas Business Overview
- 6.15.3 Astellas Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Astellas Novel Drug Delivery Systems Product Portfolio
- 6.15.5 Astellas Recent Developments
- 6.16 AMAG Pharmaceuticals
- 6.16.1 AMAG Pharmaceuticals Company Information
- 6.16.2 AMAG Pharmaceuticals Business Overview
- 6.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 6.16.5 AMAG Pharmaceuticals Recent Developments
- 6.17 AbbVie
- 6.17.1 AbbVie Company Information
- 6.17.2 AbbVie Business Overview
- 6.17.3 AbbVie Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 AbbVie Novel Drug Delivery Systems Product Portfolio
- 6.17.5 AbbVie Recent Developments
- 6.18 Dr Reddy
- 6.18.1 Dr Reddy Company Information
- 6.18.2 Dr Reddy Business Overview
- 6.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Dr Reddy Novel Drug Delivery Systems Product Portfolio
- 6.18.5 Dr Reddy Recent Developments
- 6.19 AstraZeneca
- 6.19.1 AstraZeneca Company Information
- 6.19.2 AstraZeneca Business Overview
- 6.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 AstraZeneca Novel Drug Delivery Systems Product Portfolio
- 6.19.5 AstraZeneca Recent Developments
- 6.20 Aspen
- 6.20.1 Aspen Company Information
- 6.20.2 Aspen Business Overview
- 6.20.3 Aspen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Aspen Novel Drug Delivery Systems Product Portfolio
- 6.20.5 Aspen Recent Developments
- 6.21 Acrotech Biopharma
- 6.21.1 Acrotech Biopharma Company Information
- 6.21.2 Acrotech Biopharma Business Overview
- 6.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Acrotech Biopharma Novel Drug Delivery Systems Product Portfolio
- 6.21.5 Acrotech Biopharma Recent Developments
- 6.22 TWi Pharmaceuticals
- 6.22.1 TWi Pharmaceuticals Company Information
- 6.22.2 TWi Pharmaceuticals Business Overview
- 6.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
- 6.22.5 TWi Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Novel Drug Delivery Systems Market Size by Country (2021-2026)
- 7.3 North America Novel Drug Delivery Systems Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Novel Drug Delivery Systems Market Size by Country (2021-2026)
- 8.3 Europe Novel Drug Delivery Systems Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Novel Drug Delivery Systems Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Novel Drug Delivery Systems Market Size by Country (2021-2026)
- 10.3 South America Novel Drug Delivery Systems Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Novel Drug Delivery Systems Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst